NeuroGenesis reveals positive survival outcomes in patients with ALS treated with “NG01”, a novel cell therapy in a new publication. This study provides compelling indications that NG01 therapies can ...
The CEO Challenge, much like the ice bucket challenge, raises money for and awareness about this fatal disease. Thirty thousand people are currently living with ALS--the life expectancy two to five ...
11don MSN
New ALS drug stabilizes decline with a trend toward improved strength and mobility for some
Historically, people with amyotrophic lateral sclerosis (ALS) experience a relentless decline in neurological function that ...
PHOENIX (AZFamily) — A new California study is showing promising results to give amyotrophic lateral sclerosis (ALS) patients in Arizona and nationwide a faster diagnosis and more time to live. Ernie ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback